South San Francisco, CA · Founded 2022 · Privately Held (backing)
Developer of an oncology technology platform designed for cancer treatment. Shenandoah Therapeutics is based in South San Francisco, CA and was founded in 2022. Its last reported valuation was $37 million in Mar 2025. It has raised $21.5 million across 1 recorded round; the latest was a $21.5 million early-stage round in May 2025.
Last reported valuation
$37.0M
Oct 2026
Priced at
—
Total raised
$21.5M
Last round
Early Stage VC
May 2025
Cap table — not yet on record
Shenandoah Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Shenandoah Therapeutics with a free Private Market View account
·Watch Shenandoah Therapeutics: the Monday email on marks, rounds and moves
Where does Shenandoah Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Shenandoah Therapeutics's 1 recorded funding rounds.
